← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2002Last known activity
Nov 20, 2020
Timeline
1960s
- Mar 29, 1962
Korea Cancer Center Hospital— Founded
Drugs by trial phase (19 distinct, 19 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Encephalitis
- Encephalitis, Japanese
- Hot Flashes
- Immunoblastic Lymphadenopathy
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Ovarian Neoplasms
- Stomach Neoplasms
- Uterine Cervical Neoplasms
Recent trials (26)
- NCT04628143Overall official - principal investigatorPhase 2Nov 20, 2020
- NCT02819921CollaboratorPhase 4May 1, 2017
- NCT02433795CollaboratorPhase 2May 1, 2015
- NCT02280785Overall official - principal investigatorPhase 2Nov 1, 2014
- NCT02205008CollaboratorPhase 3Oct 1, 2012
- NCT01678417Lead sponsorPhase 2Jun 1, 2012
- NCT01676558Lead sponsorPhase 2Jun 1, 2012
- NCT01561586Lead sponsorPhase 3Mar 1, 2012
- NCT01561586Reponsible party - principal investigatorPhase 3Mar 1, 2012
- NCT01678404Lead sponsorPhase 2Oct 1, 2011
- NCT01194609Lead sponsorPhase 1/Phase 2Sep 1, 2010
- NCT01194609Reponsible party - principal investigatorPhase 1/Phase 2Sep 1, 2010
- NCT01150942CollaboratorPhase 3Aug 1, 2010
- NCT01198665CollaboratorPhase 1/Phase 2Jul 1, 2010
- NCT01068392CollaboratorPhase 2Oct 1, 2009
Details
- Founded
- Seoul, KR Mar 29, 1962
- Last known activity
- Nov 20, 2020